Dinaciclib in Treating Patients With Stage III-IV Melanoma

Clinical trial NCT01026324 · TERMINATED

Trial details

NCT number: NCT01026324
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma

Start date: 2009-09-01
Primary completion: 2014-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.